More good safety results as Prescient Therapeutics continues cancer treatment tests
Australian biotech company Prescient Therapeutics has successfully finished a round of safety testing on its...
Australian biotech company Prescient Therapeutics has successfully finished a round of safety testing on its...
The US Food and Drug Administration has assigned a fast track designation to a new...
Shares in biotech company, Prescient Therapeutics, have proved buoyant this week after initial immunogenicity testing...
The terrible news this week that Tmunity Therapeutics, a clinical stage biotherapeutics company, has halted...
Australia’s medical community has welcomed a new ‘patent box’ tax regime designed to encourage further...
Prescient Therapeutics has inked a new deal with leading research organisation Peter MacCallum Cancer Centre...
The market for revolutionary CAR-T cancer treatments is expected to grow to USD 14 billion...
When JVC launched VHS videos in 1971, it started a consumer revolution that permanently altered...
The burgeoning CAR T therapy industry has passed another significant milestone after the US Food...
Australian listed biotech company Prescient Therapeutics (ASX: PTX) is forging a path for other prospective...
To stay up to date with Prescient Therapeutics news and events, please register your details.